Moderna Takes Middle Ground On Pricing With 100 Million Dose US Agreement

Looking At $30.50 Per Course

Pricing set somewhere down the middle as Moderna reaches deal with US government on initial supplies of its mRNA coronavirus vaccine.

Aerial overhead view of trailer trucks delivering a vaccine. 3D rendering
Another Supply Deal As Vaccine Race Intensifies • Source: Shutterstock

Moderna, Inc.’s shares jumped more than 8% in after-hours trading on 11 August after the vaccine developer announced it had reached an agreement with the US government to supply an initial 100 million doses of its mRNA coronavirus candidate mRNA-1273.

Up to $1.525bn has been awarded for the manufacture and delivery of this first tranche of doses - including incentive...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip